Monday, May 10, 2021 |

Emergent BioSolutions CEO sold millions in stock in months before Covid-19 vaccine snafu

April 27, 2021

Emergent BioSolutions Inc. CEO Bob Kramer sold more than $10 million worth of stock in the company in January and early February, according to Securities and Exchange Commission filings — just before shares in the Gaithersburg company took a dip following the release of its annual financial report. The company’s share price fell even further after it was revealed in late March that Emergent was responsible for mixing up ingredients for two Covid-19 vaccines at its Baltimore manufacturing facility — a snafu that has brought on a wave of criticism, big operational changes at the plant, increased federal oversight, a lawsuit and a pause on all vaccine production.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.